Host-microbe interactions that facilitate gut colonization by commensal bifidobacteria

Trends in Microbiology

Volumn 20, Issue 10, 2012, Pages 467-476

  Ventura, Marco ^a   Turroni, Francesca ^b   Motherway, Mary O'Connell ^b   MacSharry, John ^b   van Sinderen, Douwe ^b  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Bifidobacteria; Genomics; Gut microbiota; Host microbe crosstalk

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIOCIN; TRANSCRIPTOME;

ADAPTATION; BACTERIAL COLONIZATION; BACTERIUM PILUS; BIFIDOBACTERIUM; BREAST FEEDING; CHILDHOOD; COMMENSALISM; DIET; GASTROINTESTINAL TRACT; GENE SEQUENCE; GENETIC TRANSCRIPTION; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; INTESTINE FLORA; MICROBIAL COMMUNITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

BIFIDOBACTERIUM; GASTROINTESTINAL TRACT; HUMANS;

BACTERIA (MICROORGANISMS);

EID: 84866895877     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2012.07.002     Document Type: Review

References (95)

1. Backhed F., et al. Host-bacterial mutualism in the human intestine. Science 2005, 307:1915-1920.
2. Eckburg P.B., et al. Diversity of the human intestinal microbial flora. Science 2005, 308:1635-1638.
3. Rajilic-Stojanovic M., et al. Diversity of the human gastrointestinal tract microbiota revisited. Environ. Microbiol. 2007, 9:2125-2136.
4. Qin J., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464:59-65.
5. Backhed F., et al. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:979-984.
6. Claesson M.J., et al. Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(Suppl. 1):4586-4591.
7. Turroni F., et al. Microbiomic analysis of the bifidobacterial population in the human distal gut. ISME J. 2009, 3:745-751.
8. Koenig J.E., et al. Succession of microbial consortia in the developing infant gut microbiome. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(Suppl. 1):4578-4585.
9. Vaishampayan P.A., et al. Comparative metagenomics and population dynamics of the gut microbiota in mother and infant. Genome Biol. Evol. 2010, 2:53-66.
10. Gueimonde M., et al. Breast milk: a source of bifidobacteria for infant gut development and maturation?. Neonatology 2007, 92:64-66.
11. Caicedo R.A., et al. The developing intestinal ecosystem: implications for the neonate. Pediatr. Res. 2005, 58:625-628.
12. Kaplan J.L., et al. The role of microbes in developmental immunologic programming. Pediatr. Res. 2011, 69:465-472.
13. Adlerberth I., et al. Reduced enterobacterial and increased staphylococcal colonization of the infantile bowel: an effect of hygienic lifestyle?. Pediatr. Res. 2006, 59:96-101.
14. Thavagnanam S., et al. A meta-analysis of the association between Caesarean section and childhood asthma. Clin. Exp. Allergy 2008, 38:629-633.
15. Bager P., et al. Caesarean delivery and risk of atopy and allergic disease: meta-analyses. Clin. Exp. Allergy 2008, 38:634-642.
16. Lathrop S.K., et al. Peripheral education of the immune system by colonic commensal microbiota. Nature 2011, 478:250-254.
17. Olszak T., et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012, 336:489-493.
18. Turroni F., et al. Diversity of bifidobacteria within the infant gut microbiota. PLoS ONE 2012, 7:e36957.
19. Sela D.A., et al. The genome sequence of Bifidobacterium longum subsp. infantis reveals adaptations for milk utilization within the infant microbiome. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:18964-18969.
20. Yoshida E., et al. Bifidobacterium longum subsp. infantis uses two different beta-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides. Glycobiology 2012, 22:361-368.
21. Oddy W.H., et al. Breast feeding and respiratory morbidity in infancy: a birth cohort study. Arch. Dis. Child. 2003, 88:224-228.
22. Labbok M.H., et al. Breastfeeding: maintaining an irreplaceable immunological resource. Nat. Rev. Immunol. 2004, 4:565-572.
23. Chichlowski M., et al. Bifidobacteria isolated from infants and cultured on human milk oligosaccharides affect intestinal epithelial function. J. Pediatr. Gastroenterol. Nutr. 2012, 55:321-327.
24. Vickery B.P., et al. Mechanisms of immune tolerance relevant to food allergy. J. Allergy Clin. Immunol. 2011, 127:576-584.
25. Garrett W.S., et al. Homeostasis and inflammation in the intestine. Cell 2010, 140:859-870.
26. McLoughlin R.M., Mills K.H. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J. Allergy Clin. Immunol. 2011, 127:1097-1107. quiz 1108-1099.
27. Sanderson I.R., Walker W.A. TLRs in the Gut I. The role of TLRs/Nods in intestinal development and homeostasis. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 292:G6-G10.
28. Kawai T., Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011, 34:637-650.
29. Rakoff-Nahoum S., et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118:229-241.
30. Frantz A.L., et al. Targeted deletion of MyD88 in intestinal epithelial cells results in compromised antibacterial immunity associated with downregulation of polymeric immunoglobulin receptor, mucin-2, and antibacterial peptides. Mucosal Immunol. 2012, 10.1038/mi.2012.23.
31. Smith P.D., et al. Intestinal macrophages and response to microbial encroachment. Mucosal Immunol. 2011, 4:31-42.
32. Franchi L., et al. NLRC4-driven production of IL-1beta discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nat. Immunol. 2012, 13:449-456.
33. Mazmanian S.K., et al. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
34. Hooper L.V., et al. Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat. Immunol. 2003, 4:269-273.
35. Vael C., Desager K. The importance of the development of the intestinal microbiota in infancy. Curr. Opin. Pediatr. 2009, 21:794-800.
36. Lopez P., et al. Treg-inducing membrane vesicles from Bifidobacterium bifidum LMG13195 as potential adjuvants in immunotherapy. Vaccine 2012, 30:825-829.
37. Sonnenburg J.L., et al. Genomic and metabolic studies of the impact of probiotics on a model gut symbiont and host. PLoS Biol. 2006, 4:e413.
38. Denou E., et al. Identification of genes associated with the long-gut-persistence phenotype of the probiotic Lactobacillus johnsonii strain NCC533 using a combination of genomics and transcriptome analysis. J. Bacteriol. 2008, 190:3161-3168.
39. Ventura M., et al. Genome-scale analyses of health-promoting bacteria: probiogenomics. Nat. Rev. Microbiol. 2009, 7:61-71.
40. Ventura M., et al. Genomics of Actinobacteria: tracing the evolutionary history of an ancient phylum. Microbiol. Mol. Biol. Rev. 2007, 71:495-548.
41. Turroni F., et al. Genomics and ecological overview of the genus Bifidobacterium. Int. J. Food Microbiol. 2011, 149:37-44.
42. Pokusaeva K., et al. Carbohydrate metabolism in bifidobacteria. Genes Nutr. 2011, 6:285-306.
43. Forstner O.M., Sylvester F.A. Production, Structure and Biologic Relevance of Gastrointestinal Mucins 1995, Raven Press.
44. Turroni F., et al. Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:19514-19519.
45. Derrien M., et al. The Mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Environ. Microbiol. 2008, 74:1646-1648.
46. Collado M.C., et al. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol. 2007, 73:7767-7770.
47. Derrien M., et al. Mucin-bacterial interactions in the human oral cavity and digestive tract. Gut. Microbes 2010, 1:254-268.
48. Derrien M., et al. Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila. Front. Microbiol. 2011, 2:166.
49. van Passel M.W., et al. The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes. PLoS ONE 2011, 6:e16876.
50. Derrien M., et al. Akkermansia muciniphila gen. nov. sp. nov. a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 2004, 54:1469-1476.
51. Martens E.C., et al. Mucosal glycan foraging enhances fitness and transmission of a saccharolytic human gut bacterial symbiont. Cell Host Microbe 2008, 4:447-457.
52. Png C.W., et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 2010, 105:2420-2428.
53. Turroni F., et al. Genetic strategies for mucin metabolism in Bifidobacterium bifidum PRL2010: an example of possible human-microbe co-evolution. Gut. Microbes 2011, 2:183-189.
54. Asakuma S., et al. Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. J. Biol. Chem. 2011, 286:34583-34592.
55. Sela D.A. Bifidobacterial utilization of human milk oligosaccharides. Int. J. Food Microbiol. 2011, 149:58-64.
56. Marcobal A., et al. Bacteroides in the infant gut consume milk oligosaccharides via mucus-utilization pathways. Cell Host Microbe 2011, 10:507-514.
57. Ventura M., et al. How high G+C Gram-positive bacteria and in particular bifidobacteria cope with heat stress: protein players and regulators. FEMS Microbiol. Rev. 2006, 30:734-759.
58. Zomer A., et al. An interactive regulatory network controls stress response in Bifidobacterium breve UCC2003. J. Bacteriol. 2009, 191:7039-7049.
59. Pizarro-Cerda J., Cossart P. Bacterial adhesion and entry into host cells. Cell 2006, 124:715-727.
60. Xu J., et al. Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol. 2007, 5:e156.
61. Bry L., et al. A model of host-microbial interactions in an open mammalian ecosystem. Science 1996, 273:1380-1383.
62. Krinos C.M., et al. Extensive surface diversity of a commensal microorganism by multiple DNA inversions. Nature 2001, 414:555-558.
63. Coyne M.J., Comstock L.E. Niche-specific features of the intestinal bacteroidales. J. Bacteriol. 2008, 190:736-742.
64. Mazmanian S.K., Kasper D.L. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat. Rev. Immunol. 2006, 6:849-858.
65. Johri A.K., et al. Group B Streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol. 2006, 4:932-942.
66. Round J.L., et al. The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 2011, 332:974-977.
67. Liu C.H., et al. Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3951-3956.
68. Kuwahara T., et al. Genomic analysis of Bacteroides fragilis reveals extensive DNA inversions regulating cell surface adaptation. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:14919-14924.
69. Cerdeno-Tarraga A.M., et al. Extensive DNA inversions in the B. fragilis genome control variable gene expression. Science 2005, 307:1463-1465.
70. O'Connell Motherway M., et al. Functional genome analysis of Bifidobacterium breve UCC2003 reveals type IVb tight adherence (Tad) pili as an essential and conserved host-colonization factor. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:11217-11222.
71. Fanning S., et al. Bifidobacterial surface-exopolysaccharide facilitates commensal-host interaction through immune modulation and pathogen protection. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:2108-2113.
72. Telford J.L., et al. Pili in gram-positive pathogens. Nat. Rev. Microbiol. 2006, 4:509-519.
73. Kankainen M., et al. Comparative genomic analysis of Lactobacillus rhamnosus GG reveals pili containing a human-mucus binding protein. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:17193-17198.
74. Lebeer S., et al. Functional analysis of Lactobacillus rhamnosus GG pili in relation to adhesion and immunomodulatory interactions with intestinal epithelial cells. Appl. Environ. Microbiol. 2012, 78:185-193.
75. von Ossowski I., et al. Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits. Appl. Environ. Microbiol. 2010, 76:2049-2057.
76. Reunanen J., et al. Characterization of the SpaCBA pilus fibers in the probiotic Lactobacillus rhamnosus GG. Appl. Environ. Microbiol. 2012, 78:2337-2344.
77. Tomich M., et al. The tad locus: postcards from the widespread colonization island. Nat. Rev. Microbiol. 2007, 5:363-375.
78. Foroni E., et al. Genetic analysis and morphological identification of pilus-like structures in members of the genus Bifidobacterium. Microb. Cell Fact. 2011, 10(Suppl. 1):S16.
79. Potempa J., et al. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 1994, 269:15957-15960.
80. Turroni F., et al. Characterization of the serpin-encoding gene of Bifidobacterium breve 210B. Appl. Environ. Microbiol. 2010, 76:3206-3219.
81. Ivanov D., et al. A serpin from the gut bacterium Bifidobacterium longum inhibits eukaryotic elastase-like serine proteases. J. Biol. Chem. 2006, 281:17246-17252.
82. Guglielmetti S., et al. Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells. Appl. Environ. Microbiol. 2008, 74:4695-4702.
83. Fukuda S., et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 2011, 469:543-547.
84. De Vuyst L., Leroy F. Cross-feeding between bifidobacteria and butyrate-producing colon bacteria explains bifdobacterial competitiveness, butyrate production, and gas production. Int. J. Food Microbiol. 2011, 149:73-80.
85. Wong J.M., et al. Colonic health: fermentation and short chain fatty acids. J. Clin. Gastroenterol. 2006, 40:235-243.
86. Klaenhammer T.R. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 1993, 12:39-85.
87. Dobson A., et al. Bacteriocin production: a probiotic trait?. Appl. Environ. Microbiol. 2012, 78:1-6.
88. Corr S.C., et al. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:7617-7621.
89. Gotteland M., et al. Modulation of Helicobacter pylori colonization with cranberry juice and Lactobacillus johnsonii La1 in children. Nutrition 2008, 24:421-426.
90. Yildirim Z., Johnson M.G. Characterization and antimicrobial spectrum of bifidocin B, a bacteriocin produced by Bifidobacterium bifidum NCFB 1454. J. Food Prot. 1998, 61:47-51.
91. Yildirim Z., et al. Purification, amino acid sequence and mode of action of bifidocin B produced by Bifidobacterium bifidum NCFB 1454. J. Appl. Microbiol. 1999, 86:45-54.
92. Mathys S., et al. Co-cultivation of a bacteriocin-producing mixed culture of Bifidobacterium thermophilum RBL67 and Pediococcus acidilactici UVA1 isolated from baby faeces. J. Appl. Microbiol. 2009, 107:36-46.
93. Lee J.H., et al. Transcription analysis of a lantibiotic gene cluster from Bifidobacterium longum DJO10A. Appl. Environ. Microbiol. 2011, 77:5879-5887.
94. Kato S., et al. Stable coexistence of five bacterial strains as a cellulose-degrading community. Appl. Environ. Microbiol. 2005, 71:7099-7106.
95. Tannock G.W., et al. Resource partitioning in relation to cohabitation of Lactobacillus species in the mouse forestomach. ISME J. 2012, 6:927-938.